期刊文献+

冠状动脉旁路移植术医院感染病原菌分析 被引量:5

Pathogenic bacteria causing nosocomial infections in 9375 patients after coronary artery bypass grafting
原文传递
导出
摘要 目的总结北京市冠状动脉旁路移植术(CABG)术后感染情况,分析CABG医院感染的危险因素及控制环节,更好地控制感染,降低病死率。方法北京市医院感染管理质量控制和改进中心组织本市多中心进行CABG目标性监测。结果调查2008-2010年3年CABG手术9375例,检出病原菌249株,检出率为2.66%,其中鲍氏不动杆菌、铜绿假单胞菌、白色假丝酵母菌、表皮葡萄球菌、肺炎克雷伯菌位居前5位,分别占27.31%、12.45%、9.64%、8.43%、8.43%。结论对CABG术后感染,应根据实际情况和参考统计信息,采取针对措施,加强医院感染危险因素的预防控制,合理应用抗菌药物,控制医院感染,保障患者手术安全。 OBJECTIVE To investigate the incidence of infections in Beijing after the coronary artery bypass grafting(CABG)and analyze the risk factors of nosocomial infections after CABG and the control links so as to control the infections and reduce the mortality.METHODS The targeted monitoring of CABG was performed in Beijing Hospital Infection Control Quality Management and Control Center.RESULTS Of totally 9375 CABG cases investigated in 2008-2010,there were 249strains o f pathogens isolated with the detection rate of 2.66%,among which the Acinetobater baumannii,Pseudomonas aeruginosa,Candida albicans,Staphylococcus epidermidis,and Klebsiella pneumoniae ranked the top five species,accounting for 27.31%,12.45%,9.64%,8.43%,and 8.43%,respectively.CONCLUSION For the CABG patients after infections,it is necessary to take targeted measures,strengthen the prevention of risk factors of nosocomial infections,and reasonably use antibiotics so as to control the nosocomial infections and ensure the safety of operation.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第13期3262-3263,3266,共3页 Chinese Journal of Nosocomiology
基金 首都医学发展科研基金(2011-管-04)
关键词 冠状动脉旁路移植术 医院感染 病原菌 Coronary artery bypass grafting Nosocomial infection Pathogenic bacteria
  • 相关文献

参考文献4

二级参考文献20

  • 1陈文光,章泽豹,蒋景华.普外科围手术期预防性使用抗菌药物调查分析[J].中华医院感染学杂志,2004,14(12):1406-1409. 被引量:84
  • 2郭亚春,陈文光,章泽豹,陶映,蒋景华.无菌手术切口感染危险因素调查分析[J].中华医院感染学杂志,2007,17(4):394-396. 被引量:63
  • 3王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 4毕春宇.94株鲍曼不动杆菌所致医院感染的耐药性分析[J].中国热带医学,2007,7(6):967-968. 被引量:18
  • 5World Alliance for Patient Safety: Global Patient Safety Challenge. 2005-2006. Clean Care is Safer Care. WHO.
  • 6Nichols, RL. Mar-Apr 2001. Preventing Surgical Site Infections: A Surgeon's Perspective, Emerging Infectious Diseases. 7(2).
  • 7Zarrulli R,Crispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resist ance[J]. J Ciin Microbiol, 2004,42 (3) : 946-953.
  • 8Yoon J, Urban C,Terzian C,et al. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multi drug-resistant Acinetobacter baurnanni[J]. Anti mierob Agents Chemother, 2004,48(3) : 753- 757.
  • 9Segers P, de Jong AP, Kloek JJ, etal. Risk control of surgical site infection after cardiothoracic surgery[J]. J Hosp Infect,2006,62(4) :437-445.
  • 10Haas JP, Evans AM, Preston KE, etal. Risk factors for surgical site infection after cardiac surgery; the role of endogenous flora [J]. Heart Lung,200S,34(2):108-114.

共引文献34

同被引文献37

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部